Exact Mass: 297.1147

Exact Mass Matches: 297.1147

Found 183 metabolites which its exact mass value is equals to given mass value 297.1147, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Psicofuranine

9-D-Psicofuranosyl-6-aminopurine

C11H15N5O5 (297.1073)


   

2-Methylguanosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(methylamino)-6,9-dihydro-3H-purin-6-one

C11H15N5O5 (297.1073)


2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127) [HMDB] 2-Methylguanosine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, the DNA becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 17336316, 17154124, 3506820, 17044778, 17264127). N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.

   

Duloxetine

methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine

C18H19NOS (297.1187)


Duloxetine (brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim) is a drug which primarily targets major depressive disorder (MDD), generalized anxiety disorder (GAD), pain related to diabetic peripheral neuropathy and in some countries stress urinary incontinence (SUI). It is manufactured and marketed by Eli Lilly and Company. Duloxetine has not yet been FDA approved for stress urinary incontinence or for fibromyalgia. Duloxetine is a selective SNRI (selective serotonin-norepinephrine reuptake inhibitor). Duloxetine is a systemic drug therapy which affects the body as a whole. Known also under the code name LY248686, it is a potent dual reuptake inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE), possessing comparable affinities in binding to NE- and 5-HT transporter sites. It is a less potent inhibitor of dopamine reuptake. D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

1-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-6,9-dihydro-1H-purin-6-one

C11H15N5O5 (297.1073)


1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours. These nucleosides have been proposed as tumour markers. Their measurement could provide a non-invasive diagnostic method, help identify different cancers, and monitor any therapeutic effects (PMID:9129323). 1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumours and they have been proposed as tumour markers. Their 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].

   

3'-O-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-6,9-dihydro-3H-purin-6-one

C11H15N5O5 (297.1073)


3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933) [HMDB] 3-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. (PMID: 3506820, 17044778, 17264127, 16799933). 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

   

Nelarabine

(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O5 (297.1073)


Nelarabine is only found in individuals that have used or taken this drug. It is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate (araGTP), resulting in inhibition of DNA synthesis and cytotoxicity.Once nelarabine is metabolized into ara-GTP, the metabolite accumulates in leukemic blasts and incorporates into DNA to exert its S phase-specific cytotoxic effects, leading to the induction of fragmentation and apoptosis. Ara-GTP competes with endogenous deoxyGTP (dGTP) for incorporation into DNA. Once ara-GTP is incorporated at the 3 end of DNA, further DNA elongation is inhibited, which signals apoptosis and leads to cellular destruction. Additional cytotoxic activities may exist, but these are not fully understood. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].

   

Phenethylamine glucuronide

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2-phenylethyl)amino]oxane-2-carboxylic acid

C14H19NO6 (297.1212)


Phenethylamine glucuronide is a natural human metabolite of Phenethylamine generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Phenethylamine glucuronide is a natural human metabolite of Phenethylamine generated in the liver by UDP glucuonyltransferase.

   

2'-C-Methylguanosine

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C11H15N5O5 (297.1073)


   

5-Hydroxymebendazole

methyl N-{5-[hydroxy(phenyl)methyl]-3H-1,3-benzodiazol-2-yl}carbamate

C16H15N3O3 (297.1113)


   

Calcium diglutamate

Ethyl 3-methyl-7-oxo-2-phenyl-1H,7H-pyrazolo[1,5-a]pyrimidine-6-carboxylic acid

C16H15N3O3 (297.1113)


Flavour enhancer; salt substitute. Calcium diglutamate, sometimes abbreviated CDG and also called calcium glutamate, is a compound with formula Ca(C5H8NO4)2. It is a calcium acid salt of glutamic acid. CDG is a flavor enhancer (E number E623) ? it is the calcium analog of monosodium glutamate (MSG). Because the glutamate is the actual flavor-enahancer, DCG has the same flavor-enhancing properties as MSG, but without the increased sodium content. As a soluble source of calcium ions, this chemical is also used as a first-aid treatment for exposure to hydrofluoric acid. Flavour enhancer; salt substitute

   
   

2-O-methylguanosine

2`-O-Methylguanosine

C11H15N5O5 (297.1073)


Guanosine with the hydrogen on the hydroxyl at position C-2 substituted with a methyl group. CONFIDENCE standard compound; INTERNAL_ID 318 2'-O-Methylguanosine is a modified nucleoside produced in tRNAs by the action of tRNA guanosine-2’-O-methyltransferase. 2'-O-Methylguanosine results in apoptotic changes of cells[1][2].

   

5-Hydroxymebendazole

5-Hydroxymebendazole

C16H15N3O3 (297.1113)


   

Maybridge3_004494

Maybridge3_004494

C15H15N5S (297.1048)


   

Ethyl 2-cyano-3-[(6-methoxy-8-quinolyl)amino]acrylate

Ethyl 2-cyano-3-[(6-methoxy-8-quinolyl)amino]acrylate

C16H15N3O3 (297.1113)


   

N(6)-OH-Me-Adenosine

N(6)-OH-Me-Adenosine

C11H15N5O5 (297.1073)


consensus spectrum

   

7-Methylguanosine

2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-6-oxo-6,7-dihydro-3H-1,3,7,9$l^{5}-purin-9-ylium

C11H15N5O5 (297.1073)


   
   

spirostaphylotrichin U

spirostaphylotrichin U

C14H19NO6 (297.1212)


   

Nordomoic acid

Nordomoic acid

C14H19NO6 (297.1212)


   

Adenosine, 2-methoxy-

Adenosine, 2-methoxy-

C11H15N5O5 (297.1073)


   
   

SCHEMBL14614880

SCHEMBL14614880

C11H15N5O5 (297.1073)


   

spirostaphylotrichin S

spirostaphylotrichin S

C14H19NO6 (297.1212)


   

4-hydroxyphenylethanamide-alpha-L-rhamnopyranoside|marumoside A

4-hydroxyphenylethanamide-alpha-L-rhamnopyranoside|marumoside A

C14H19NO6 (297.1212)


   

dimethyl 2-[2-formyl-5-(methoxymethyl)-1H-pyrrol-1-yl]pentanedioate

dimethyl 2-[2-formyl-5-(methoxymethyl)-1H-pyrrol-1-yl]pentanedioate

C14H19NO6 (297.1212)


   

SCHEMBL16389310

SCHEMBL16389310

C14H19NO6 (297.1212)


   

4-methylaminobenzoyl rhamnopyranoside

4-methylaminobenzoyl rhamnopyranoside

C14H19NO6 (297.1212)


   

catechoserine

catechoserine

C14H19NO6 (297.1212)


   

JANEX-1

4-[(6,7-dimethoxy-4-quinazolinyl)amino]-phenol

C16H15N3O3 (297.1113)


   

Nelarabine

Nelarabine (Arranon)

C11H15N5O5 (297.1073)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BB - Purine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].

   
   

(3,4,5-trihydroxy-6-methyloxan-2-yl) 2-(methylamino)benzoate

NCGC00179746-02!(3,4,5-trihydroxy-6-methyloxan-2-yl) 2-(methylamino)benzoate

C14H19NO6 (297.1212)


   

Duloxetine

methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine

C18H19NOS (297.1187)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 2735 CONFIDENCE standard compound; INTERNAL_ID 8509

   

1-methylguanosine

1-methylguanosine

C11H15N5O5 (297.1073)


Guanosine substituted with a methyl group at position N-1. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1]. 1-Methylguanosine is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker[1].

   

3-O-Methylguanosine

Guanosine, 3-O-methyl-

C11H15N5O5 (297.1073)


Guanosine with the hydrogen on the hydroxyl at position C-3 substituted with a methyl group. 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

   

N2-Methylguanosine

N2-Methylguanosine

C11H15N5O5 (297.1073)


   

(3,4,5-trihydroxy-6-methyloxan-2-yl) 2-(methylamino)benzoate

(3,4,5-trihydroxy-6-methyloxan-2-yl) 2-(methylamino)benzoate

C14H19NO6 (297.1212)


   

N-Methylguanosine

N(2)-Methylguanosine

C11H15N5O5 (297.1073)


CONFIDENCE standard compound; INTERNAL_ID 319 N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's. N2-methylguanosine is a modified nucleoside that occurs at several specific locations in many tRNA's.

   

N1-Methylguanosine; LC-tDDA; CE10

N1-Methylguanosine; LC-tDDA; CE10

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; LC-tDDA; CE20

N1-Methylguanosine; LC-tDDA; CE20

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; LC-tDDA; CE30

N1-Methylguanosine; LC-tDDA; CE30

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; LC-tDDA; CE40

N1-Methylguanosine; LC-tDDA; CE40

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE0; CorrDec

7-Methylguanosine; AIF; CE0; CorrDec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE10; CorrDec

7-Methylguanosine; AIF; CE10; CorrDec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE30; CorrDec

7-Methylguanosine; AIF; CE30; CorrDec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE0; MS2Dec

7-Methylguanosine; AIF; CE0; MS2Dec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE10; MS2Dec

7-Methylguanosine; AIF; CE10; MS2Dec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; AIF; CE30; MS2Dec

7-Methylguanosine; AIF; CE30; MS2Dec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE0; CorrDec

N2-Methylguanosine; AIF; CE0; CorrDec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE10; CorrDec

N2-Methylguanosine; AIF; CE10; CorrDec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE30; CorrDec

N2-Methylguanosine; AIF; CE30; CorrDec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE0; MS2Dec

N2-Methylguanosine; AIF; CE0; MS2Dec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE10; MS2Dec

N2-Methylguanosine; AIF; CE10; MS2Dec

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; AIF; CE30; MS2Dec

N2-Methylguanosine; AIF; CE30; MS2Dec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE0; CorrDec

N1-Methylguanosine; AIF; CE0; CorrDec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE10; CorrDec

N1-Methylguanosine; AIF; CE10; CorrDec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE30; CorrDec

N1-Methylguanosine; AIF; CE30; CorrDec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE0; MS2Dec

N1-Methylguanosine; AIF; CE0; MS2Dec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE10; MS2Dec

N1-Methylguanosine; AIF; CE10; MS2Dec

C11H15N5O5 (297.1073)


   

N1-Methylguanosine; AIF; CE30; MS2Dec

N1-Methylguanosine; AIF; CE30; MS2Dec

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE10

7-Methylguanosine; LC-tDDA; CE10

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE20

7-Methylguanosine; LC-tDDA; CE20

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE30

7-Methylguanosine; LC-tDDA; CE30

C11H15N5O5 (297.1073)


   

7-Methylguanosine; LC-tDDA; CE40

7-Methylguanosine; LC-tDDA; CE40

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE10

N2-Methylguanosine; LC-tDDA; CE10

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE20

N2-Methylguanosine; LC-tDDA; CE20

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE30

N2-Methylguanosine; LC-tDDA; CE30

C11H15N5O5 (297.1073)


   

N2-Methylguanosine; LC-tDDA; CE40

N2-Methylguanosine; LC-tDDA; CE40

C11H15N5O5 (297.1073)


   

N6-Hydroxymethyl-adenosine

N6-Hydroxymethyl-adenosine

C11H15N5O5 (297.1073)


   

Mebendazole metabolite (Carbamic acid, [5-(hydroxyphenylmethyl)-1H-benzimidazol-2-yl]-, methyl ester

Mebendazole metabolite (Carbamic acid, [5-(hydroxyphenylmethyl)-1H-benzimidazol-2-yl]-, methyl ester

C16H15N3O3 (297.1113)


   

Dibenzo[b,e]thiepin, 1-propanamine deriv

Dibenzo[b,e]thiepin, 1-propanamine deriv

C18H19NOS (297.1187)


   

3-OMG

Guanosine, 3-O-methyl-

C11H15N5O5 (297.1073)


3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-methylguanosine can inhibit early virus-specific RNA synthesis[1].

   

Phenethylamine glucuronide

Phenethylamine glucuronide

C14H19NO6 (297.1212)


   

6-Deoxy-1-O-[2-(methylamino)benzoyl]hexopyranose

6-Deoxy-1-O-[2-(methylamino)benzoyl]hexopyranose

C14H19NO6 (297.1212)


   

Boc-L-Phe chloromethyl ketone

Boc-L-Phe chloromethyl ketone

C15H20ClNO3 (297.1132)


   

2-(2-benzoylphenyl)-2-phenylacetonitrile

2-(2-benzoylphenyl)-2-phenylacetonitrile

C21H15NO (297.1154)


   

b-D-Glucopyranose,2-deoxy-2-[[(4-methoxyphenyl)methylene]amino]-

b-D-Glucopyranose,2-deoxy-2-[[(4-methoxyphenyl)methylene]amino]-

C14H19NO6 (297.1212)


   

WHI-P180

4-[3-Hydroxyanilino]-6,7-dimethoxyquinazoline

C16H15N3O3 (297.1113)


   

Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate

Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate

C14H20ClN3O2 (297.1244)


   

2-(Biphenyl-4-yl)indolizine-3-carboxaldehyde

2-(Biphenyl-4-yl)indolizine-3-carboxaldehyde

C21H15NO (297.1154)


   

tert-Butyl 4-(6-chloropyridin-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(6-chloropyridin-3-yl)piperazine-1-carboxylate

C14H20ClN3O2 (297.1244)


   

4-Amino-5-chloro-2-methoxy-N-((piperidin-4-yl)methyl)benzamide

4-Amino-5-chloro-2-methoxy-N-((piperidin-4-yl)methyl)benzamide

C14H20ClN3O2 (297.1244)


   

AV-153 free base

AV-153 free base

C14H19NO6 (297.1212)


   

N-Methyl-4-Benzenesulfonamideboronic Acid Pinacol Ester

N-Methyl-4-Benzenesulfonamideboronic Acid Pinacol Ester

C13H20BNO4S (297.1206)


   

UNII:55Z0SP2I0A

UNII:55Z0SP2I0A

C18H19NOS (297.1187)


   

4-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol

4-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol

C18H19NOS (297.1187)


   

4-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

4-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}piperidine

C14H14F3N3O (297.1089)


   

2-Methanesulfonylaminophenylboronic acid, pinacol ester

2-Methanesulfonylaminophenylboronic acid, pinacol ester

C13H20BNO4S (297.1206)


   

6-(3,5-Dimethoxyphenyl)pyrido[2,3-d]pyrimidine-2,7-diamine

6-(3,5-Dimethoxyphenyl)pyrido[2,3-d]pyrimidine-2,7-diamine

C15H15N5O2 (297.1226)


   

2-TERT-BUTOXYCARBONYLAMINO-4,5-DIMETHOXYBENZOIC ACID

2-TERT-BUTOXYCARBONYLAMINO-4,5-DIMETHOXYBENZOIC ACID

C14H19NO6 (297.1212)


   

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile

C14H15BF3NO2 (297.1148)


   

(R)-TERT-BUTYL (4-CHLORO-3-OXO-1-PHENYLBUTAN-2-YL)CARBAMATE

(R)-TERT-BUTYL (4-CHLORO-3-OXO-1-PHENYLBUTAN-2-YL)CARBAMATE

C15H20ClNO3 (297.1132)


   
   

Ethyl 1-benzyl-5-hydroxy-1,2,3,6-tetrahydro-4-pyridinecarboxylate hydrochloride (1:1)

Ethyl 1-benzyl-5-hydroxy-1,2,3,6-tetrahydro-4-pyridinecarboxylate hydrochloride (1:1)

C15H20ClNO3 (297.1132)


   

Z-L-LEU-CHLOROMETHYLKETONE

Z-L-LEU-CHLOROMETHYLKETONE

C15H20ClNO3 (297.1132)


   

ethyl 1-benzyl-5,5-difluoro-4-oxopiperidine-3-carboxylate

ethyl 1-benzyl-5,5-difluoro-4-oxopiperidine-3-carboxylate

C15H17F2NO3 (297.1176)


   
   

Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride

Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride

C15H20ClNO3 (297.1132)


   

Boc-L-phe(3,4-OH2)-OH

Boc-L-phe(3,4-OH2)-OH

C14H19NO6 (297.1212)


   

1,2-diphenyl-1h-indole-3-carbaldehyde

1,2-diphenyl-1h-indole-3-carbaldehyde

C21H15NO (297.1154)


   

tert-butyl N-[2-amino-2-(4-cyanophenyl)ethyl]carbamate,hydrochloride

tert-butyl N-[2-amino-2-(4-cyanophenyl)ethyl]carbamate,hydrochloride

C14H20ClN3O2 (297.1244)


   

tert-butyl N-[2-amino-2-(2-cyanophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(2-cyanophenyl)ethyl]carbamate

C14H20ClN3O2 (297.1244)


   

tert-butyl 4-(3-chloropyridin-2-yl)piperazine-1-carboxylate

tert-butyl 4-(3-chloropyridin-2-yl)piperazine-1-carboxylate

C14H20ClN3O2 (297.1244)


   

3-(METHANESULFONYLAMINO)PHENYLBORONIC ACID PINACOL ESTER

3-(METHANESULFONYLAMINO)PHENYLBORONIC ACID PINACOL ESTER

C13H20BNO4S (297.1206)


   

3-METHYL-5-METHOXYCARBONYL-1-BENZYL-4-PIPERIDONE HYDROCHLORIDE

3-METHYL-5-METHOXYCARBONYL-1-BENZYL-4-PIPERIDONE HYDROCHLORIDE

C15H20ClNO3 (297.1132)


   

Ethyl 4-(4-aminophenoxy)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

Ethyl 4-(4-aminophenoxy)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

C16H15N3O3 (297.1113)


   

2H-3-Benzazepin-2-one, 3-(3-chloropropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-

2H-3-Benzazepin-2-one, 3-(3-chloropropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-

C15H20ClNO3 (297.1132)


   

5-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-pyridinamine

5-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-pyridinamine

C16H15N3O3 (297.1113)


   

4-Cyano-3-fluorophenyl 4-butylbenzoate

4-Cyano-3-fluorophenyl 4-butylbenzoate

C18H16FNO2 (297.1165)


   

2-C-Methylguanosine

2-C-Methylguanosine

C11H15N5O5 (297.1073)


   

1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium inner salt

1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium inner salt

C13H19N3O3S (297.1147)


   

Zilpaterol hydrochloride

Zilpaterol hydrochloride

C14H20ClN3O2 (297.1244)


   

n-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1h-purin-2-yl]acetamide

n-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1h-purin-2-yl]acetamide

C11H15N5O5 (297.1073)


   

Methapyrilene Hydrochloride

Methapyrilene Hydrochloride

C14H20ClN3S (297.1066)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Ethyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride

Ethyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride

C15H20ClNO3 (297.1132)


   

Isofagomine D-Tartrate

Isofagomine D-Tartrate

C10H19NO9 (297.106)


   

1-Piperazinecarboxylic acid, 4-(2-chloro-4-pyridinyl)-, 1,1-dimethylethyl ester

1-Piperazinecarboxylic acid, 4-(2-chloro-4-pyridinyl)-, 1,1-dimethylethyl ester

C14H20ClN3O2 (297.1244)


   

2-[2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonylamino]acetic acid

2-[2-(3,5-dimethoxyphenyl)propan-2-yloxycarbonylamino]acetic acid

C14H19NO6 (297.1212)


   

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile

C14H15BF3NO2 (297.1148)


   

2-AMINO-3-CARBAMOYL-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRIDINE-6-CARBOXYLIC ACID TERT-BUTYL ESTER

2-AMINO-3-CARBAMOYL-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRIDINE-6-CARBOXYLIC ACID TERT-BUTYL ESTER

C13H19N3O3S (297.1147)


   

1-[(2-methylpropan-2-yl)oxycarbonyl]-4-(trifluoromethyl)piperidine-4-carboxylic acid

1-[(2-methylpropan-2-yl)oxycarbonyl]-4-(trifluoromethyl)piperidine-4-carboxylic acid

C12H18F3NO4 (297.1188)


   

5-phenyl-2-(4-phenylphenyl)-1,3-oxazole

5-phenyl-2-(4-phenylphenyl)-1,3-oxazole

C21H15NO (297.1154)


   

2,3-dimethoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]benzoic acid

2,3-dimethoxy-6-[(2-methylpropan-2-yl)oxycarbonylamino]benzoic acid

C14H19NO6 (297.1212)


   

4-(5-Formyl-thiazol-2-yl)-piperazine-1-carboxylic acid tert-butyl ester

4-(5-Formyl-thiazol-2-yl)-piperazine-1-carboxylic acid tert-butyl ester

C13H19N3O3S (297.1147)


   

Phenyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside

Phenyl 2-acetamido-2-deoxy-alpha-D-galactopyranoside

C14H19NO6 (297.1212)


   

Bimoclomol

Bimoclomol

C14H20ClN3O2 (297.1244)


C26170 - Protective Agent > C2459 - Chemoprotective Agent > C2080 - Cytoprotective Agent

   

Afegostat tartrate

Afegostat tartrate

C10H19NO9 (297.106)


C87006 - Pharmacological Chaperone

   

Tolindate

Tolindate

C18H19NOS (297.1187)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Phenyl 2-acetamido-2-deoxy-beta-D-glucopyranoside

Phenyl 2-acetamido-2-deoxy-beta-D-glucopyranoside

C14H19NO6 (297.1212)


   

N,2-dimethyl-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]furan-3-carboxamide

N,2-dimethyl-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]furan-3-carboxamide

C16H15N3O3 (297.1113)


   

N-(3-nitrophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxamide

N-(3-nitrophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxamide

C16H15N3O3 (297.1113)


   

N7-Methylguanosine

N7-Methylguanosine

C11H15N5O5 (297.1073)


   

6-(2,6-Dimethoxyphenyl)pyrido[2,3-D]pyrimidine-2,7-Diamine

6-(2,6-Dimethoxyphenyl)pyrido[2,3-D]pyrimidine-2,7-Diamine

C15H15N5O2 (297.1226)


   

Adenosine, N-(hydroxymethyl)-

Adenosine, N-(hydroxymethyl)-

C11H15N5O5 (297.1073)


   

Guanosine, 1-methyl-

Guanosine, 1-methyl-

C11H15N5O5 (297.1073)


   

(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoate

(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoate

C18H17O4- (297.1127)


   

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1H-purin-6-one

2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1H-purin-6-one

C11H15N5O5 (297.1073)


   

(R)-Duloxetine

(R)-Duloxetine

C18H19NOS (297.1187)


   

2-[(2-hydroxy-3-methoxyphenyl)methylene]-N-(3-methoxypropyl)hydrazine-1-carbothioamide

2-[(2-hydroxy-3-methoxyphenyl)methylene]-N-(3-methoxypropyl)hydrazine-1-carbothioamide

C13H19N3O3S (297.1147)


   

3-(2-Methoxy-6-methyl-3-pyridinyl)-5-(2-methoxyphenyl)-1,2,4-oxadiazole

3-(2-Methoxy-6-methyl-3-pyridinyl)-5-(2-methoxyphenyl)-1,2,4-oxadiazole

C16H15N3O3 (297.1113)


   

2-amino-3-methyl-7-(2-phenylethyl)-5H-pteridine-4,6-dione

2-amino-3-methyl-7-(2-phenylethyl)-5H-pteridine-4,6-dione

C15H15N5O2 (297.1226)


   

N-(1H-indazol-6-yl)-2,4-dimethoxybenzamide

N-(1H-indazol-6-yl)-2,4-dimethoxybenzamide

C16H15N3O3 (297.1113)


   

4-(4-Chloro-2-methylphenoxy)-1-(4-morpholinyl)-1-butanone

4-(4-Chloro-2-methylphenoxy)-1-(4-morpholinyl)-1-butanone

C15H20ClNO3 (297.1132)


   

3-(3-methoxyphenyl)-N-(3-pyridinyl)-4,5-dihydroisoxazole-5-carboxamide

3-(3-methoxyphenyl)-N-(3-pyridinyl)-4,5-dihydroisoxazole-5-carboxamide

C16H15N3O3 (297.1113)


   

1-(4-Methoxyphenyl)-3-(2-methyl-1,3-benzoxazol-5-yl)urea

1-(4-Methoxyphenyl)-3-(2-methyl-1,3-benzoxazol-5-yl)urea

C16H15N3O3 (297.1113)


   

4-Amino-3-cyclohexylcarbamoyl-isothiazole-5-carboxylic acid ethyl ester

4-Amino-3-cyclohexylcarbamoyl-isothiazole-5-carboxylic acid ethyl ester

C13H19N3O3S (297.1147)


   

2-(D-alanylamino)-N-[(1S)-1-hydroxy-3-mercaptopropyl]benzamide

2-(D-alanylamino)-N-[(1S)-1-hydroxy-3-mercaptopropyl]benzamide

C13H19N3O3S (297.1147)


   

(5Z)-5-[(2E)-3-(phenylamino)prop-2-en-1-ylidene]-1-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

(5Z)-5-[(2E)-3-(phenylamino)prop-2-en-1-ylidene]-1-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione

C16H15N3O3 (297.1113)


   

Ethyl 2-cyano-3-[(6-methoxyquinolin-8-yl)amino]prop-2-enoate

Ethyl 2-cyano-3-[(6-methoxyquinolin-8-yl)amino]prop-2-enoate

C16H15N3O3 (297.1113)


   

4-[[6,7-Bis(hydroxymethyl)-4-quinazolinyl]amino]phenol

4-[[6,7-Bis(hydroxymethyl)-4-quinazolinyl]amino]phenol

C16H15N3O3 (297.1113)


   

2-Methoxyadenosine

2-Methoxyadenosine

C11H15N5O5 (297.1073)


   

3-[(Diethoxyphosphinyl)methyl]-5-phenyl-2-isoxazoline

3-[(Diethoxyphosphinyl)methyl]-5-phenyl-2-isoxazoline

C14H20NO4P (297.113)


   

phenyl N-acetyl-beta-D-glucosaminide

phenyl N-acetyl-beta-D-glucosaminide

C14H19NO6 (297.1212)


An N-acetyl-beta-D-glucosaminide having phenyl as the anomeric substituent.

   

N(2)-Methylguanosine

N(2)-Methylguanosine

C11H15N5O5 (297.1073)


Guanosine with the hydrogen on the amine at position N-2 substituted with a methyl group.

   

N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine

N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine

C18H19NOS (297.1187)


   

phenyl N-acetyl-alpha-D-glucosaminide

phenyl N-acetyl-alpha-D-glucosaminide

C14H19NO6 (297.1212)


An N-acetyl-alpha-D-glucosaminide having phenyl as the anomeric substituent.

   

fusarithioamide A

fusarithioamide A

C13H19N3O3S (297.1147)


A member of the class of benzamides that is 2-aminobenzoic acid in which the hydrogen atom of the carboxy group has been substituted by a [(1S)-1-hydroxy-3-mercaptopropyl]nitrilo group and in which one of the the hydrogens of the amino group has been substituted by a (2R)-2-aminopropanoyl group. It is a metabolite isolated from the endophytic fungus, Fusarium chlamydosporium.

   

2'-O-Methylguanosine

2'-O-Methylguanosine

C11H15N5O5 (297.1073)


   

O-Methylguanosine

O-Methylguanosine

C11H15N5O5 (297.1073)


   

6-O-Methyl Guanosine

6-O-Methyl Guanosine

C11H15N5O5 (297.1073)


6-O-Methyl Guanosine is a modified nucleoside[1]. 6-O-Methyl Guanosine (6-methylguanosine) inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line[2].

   

7-Methylguanosine

7-Methylguanosine

C11H15N5O5 (297.1073)


7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM. 7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8?±?7.5?μM.

   

4-{5-[(4-hydroxyphenyl)methyl]-1,2,4-triazol-1-yl}-3-methoxyphenol

4-{5-[(4-hydroxyphenyl)methyl]-1,2,4-triazol-1-yl}-3-methoxyphenol

C16H15N3O3 (297.1113)


   

3,4,5-trihydroxy-6-methyloxan-2-yl 2-(methylamino)benzoate

3,4,5-trihydroxy-6-methyloxan-2-yl 2-(methylamino)benzoate

C14H19NO6 (297.1212)


   

n-[(2s)-1-butoxy-3-hydroxy-1-oxopropan-2-yl]-2,3-dihydroxybenzenecarboximidic acid

n-[(2s)-1-butoxy-3-hydroxy-1-oxopropan-2-yl]-2,3-dihydroxybenzenecarboximidic acid

C14H19NO6 (297.1212)


   

(3r,4s,5r,6r,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

(3r,4s,5r,6r,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C14H19NO6 (297.1212)


   

(3r,4r,5s,6r,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

(3r,4r,5s,6r,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C14H19NO6 (297.1212)


   

alpha-D-Arabinofuranosyladenine

(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910

C11H15N5O5 (297.1073)


{"Ingredient_id": "HBIN015484","Ingredient_name": "alpha-D-Arabinofuranosyladenine","Alias": "(2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl-; (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 9-alpha-D-Arabinofuranosyladenine; NSC 70422; 6936-84-1; AIDS023910; NSC 40584; 9H-Purin-6-amine, 9-alpha-D-arabinofuranosyl- (9CI); (2S,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Adenine, 9-alpha-D-arabinofuranosyl- (8CI); (2S,3S,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-023910","Ingredient_formula": "C11H15N5O5","Ingredient_Smile": "C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N","Ingredient_weight": "297.27","OB_score": "20.89729146","CAS_id": "6936-84-1","SymMap_id": "SMIT12080","TCMID_id": "NA","TCMSP_id": "MOL011145","TCM_ID_id": "NA","PubChem_id": "96368","DrugBank_id": "NA"}

   

3,4,6-trihydroxy-2-methoxy-3-methyl-10-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-8-ene-1,7-dione

3,4,6-trihydroxy-2-methoxy-3-methyl-10-[(1e)-prop-1-en-1-yl]-2-azaspiro[4.5]dec-8-ene-1,7-dione

C14H19NO6 (297.1212)


   

(2z,4z)-2-ethylidene-5-hydroxy-4-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)pyrrol-3-one

(2z,4z)-2-ethylidene-5-hydroxy-4-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)pyrrol-3-one

C16H15N3O3 (297.1113)


   

(1r,4r,5s)-4-(2-chloroethyl)-1-(cyclohex-2-en-1-ylmethyl)-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-4-(2-chloroethyl)-1-(cyclohex-2-en-1-ylmethyl)-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C15H20ClNO3 (297.1132)


   

(1r,4r,5s)-4-(2-chloroethyl)-1-[(1r)-cyclohex-2-en-1-ylmethyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-4-(2-chloroethyl)-1-[(1r)-cyclohex-2-en-1-ylmethyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C15H20ClNO3 (297.1132)


   

2-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)ethanimidic acid

2-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)ethanimidic acid

C14H19NO6 (297.1212)


   

(2r,3r,4s,5r)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-(6-amino-2-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O5 (297.1073)


   

2-[6-hydroxy-2-(methylimino)-3h-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-hydroxy-2-(methylimino)-3h-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O5 (297.1073)


   

(3r,4r,5s,6s,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

(3r,4r,5s,6s,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C14H19NO6 (297.1212)


   

(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2-(methylamino)benzoate

(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2-(methylamino)benzoate

C14H19NO6 (297.1212)


   

(3s,4r,5s,6s,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

(3s,4r,5s,6s,10z)-3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C14H19NO6 (297.1212)


   

3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

3,4,6-trihydroxy-2-methoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C14H19NO6 (297.1212)


   

3,4,5-trihydroxy-6-methyloxan-2-yl 4-(methylamino)benzoate

3,4,5-trihydroxy-6-methyloxan-2-yl 4-(methylamino)benzoate

C14H19NO6 (297.1212)


   

(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl 4-(methylamino)benzoate

(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl 4-(methylamino)benzoate

C14H19NO6 (297.1212)


   

(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 4-(methylamino)benzoate

(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 4-(methylamino)benzoate

C14H19NO6 (297.1212)


   

4-(2-chloroethyl)-1-(cyclohex-2-en-1-ylmethyl)-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

4-(2-chloroethyl)-1-(cyclohex-2-en-1-ylmethyl)-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C15H20ClNO3 (297.1132)